Autism: A medical primer

American Family Physician

Volumn 66, Issue 9, 2002, Pages 1667-1674

  Prater, Christopher D ^a   Zylstra, Robert G ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTICLE; AUTISM; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FRAGILE X SYNDROME; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; LANGUAGE DISABILITY; LEAD POISONING; MENTAL DEFICIENCY; MENTAL DISEASE; METABOLIC DISORDER; SEIZURE; SENSORIMOTOR FUNCTION; SOCIAL STATUS; TUBEROUS SCLEROSIS;

EID: 0036871261     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994:65-78.
2. World Health Organization. ICD-10: international statistical classification of diseases and related health problems. Geneva: World Health Organization, 1992.
3. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093-9.
4. Fombonne E, Du Mazaubrun C, Cans C, Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997;36:1561-9.
5. Bryson SE. Epidemiology of autism. J Autism Dev Disord 1996;26:165-7.
6. Fombonne E. The epidemiology of autism: a review. Psychol Med 1999;29:769-86.
7. Bryson SE. Epidemiology of autism: Overview and issues outstanding. In: Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders. 2d ed. New York: Wiley, 1997:41-6.
8. Rutter M, Bailey A, Simonoff E, Pickles A. Genetic influences and autism. In: Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders. 2d ed. New York: Wiley, 1997:370-87.
9. Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE. Genetics of autism: overview and new directions. J Autism Dev Disord 1998;28:351-68.
10. Baker P, Piven J, Sato Y. Autism and tuberous sclerosis complex: prevalence and clinical features. J Autism Dev Disord 1998;28:279-85.
11. Howlin P, Wing L, Gould J. The recognition of autism in children with Down syndrome - implications for intervention and some speculations about pathology. Dev Med Child Neurol 1995;37:406-14.
12. Anderson GM, Hoshino Y. Neurochemical studies of autism. In: Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders. 2d ed. New York: Wiley, 1997:325-43.
13. Farber JM. Autism and other communication disorders. In: Capute AJ, Accardo PJ, eds. Developmental disabilities in infancy and childhood. 2d ed. Baltimore, Md.: Brookes, 1996:347-64.
14. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
15. Miller D, Wadsworth J, Diamond J, Ross E. Measles vaccination and neurological events. Lancet 1997;349:730-1.
16. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al. Autism and measles, mumps, and,rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
17. DeStefano F, Chen RT. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. J Pediatr 2000;136:125-6.
18. Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;29:439-84.
19. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics 1992;89:91-7.
20. Sciarillo WG, Brown MM, Robinson NM, Bennett FC, Sells CJ. Effectiveness of the Denver Developmental Screening Test with biologically vulnerable infants. J Dev Behav Pediatr 1986;7:77-83.
21. Glascoe FP. Collaborating with parents: using parents' evaluation of developmental status to detect and address developmental and behavioral problems. Nashville: Ellsworth & Vandermeer, 1998.
22. Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT. Br J Psychiatry 1992;161:839-43.
23. Baird G, Charman T, Cox A, Baron-Cohen S, Swettenham J, Wheelwright S, et al. Current topic: screening and surveillance for autism and pervasive developmental disorders. Arch Dis Child 2001;84:468-75.
24. Siegel B. Early screening and diagnosis in autism spectrum disorders: the pervasive developmental disorders screening test (PDDST). NIH State of the Science in Autism: Screening and Diagnosis Working Conference, Bethesda, Md., June 15-17, 1998.
25. Filipek PA, Accardo PJ, Ashwal S, Baranek GT, Cook EH Jr, Dawson G, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000;55:468-79.
26. Gillberg C, Steffenburg S. Outcome and prognostic factors in infantile autism and similar conditions: a population-based study of 46 cases followed through puberty. J Autism Dev Disord 1987;17:273-87.
27. Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 1998;12:387-93.
28. Kobayashi R, Murata T. Behavioral characteristics of 187 young adults with autism. Psychiatry Clin Neurosci 1998;52:383-90.
29. Individuals with Disabilities Education Act-IDEA '97. Public Law 1997;105-17.
30. Arnold LE, Gadow K, Pearson D, Varley C. Stimulants. In: Reiss S, Aman MG, eds. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, Ohio: Ohio State University Nisonger Center, 1998:229-43.
31. Hagerman R, Bregman J, Tirosh E. Clonidine. In: Reiss S, Aman MG, eds. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, Ohio: Ohio State University Nisonger Center, 1998:259-69.
32. Werry JS. Anxiolytics and sedatives. In: Reiss S, Aman MG, eds. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, Ohio: Ohio State University Nisonger Center, 1998:201-14.
33. Demb HB, Espiritu C. The use of risperidone with children and adolescents with developmental disabilities: effects on some common challenging behaviors. Ment Health Aspects Dev Disabil 1999;2:73-82.
34. Volkmar F, Cook EH Jr, Pomeroy J, Realmuto G, Tanguay P. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999;38(12 suppl):32S-54S.
35. Rimland B, Edelson SM. Auditory integration training in autism: a pilot study. Autism Research Institute 1992;112:1-7.
36. Lovaas OI, Smith T. A comprehensive behavioral theory of autistic children: paradigm for research and treatment. J Behav Ther Exp Psychiatry 1989;20:17-29.
37. Sheinkopf SJ, Siegel B. Home-based behavioral treatment of young children with autism. J Autism Dev Disord 1998;28:15-23.
38. Mauk JE, Reber M, Batshaw ML. Autism and other pervasive developmental disorders. In: Batshaw ML, ed. Children with disabilities. 4th ed. Baltimore, Md.: Brookes, 1997:425-47.
39. Grandin T. Thinking in pictures: and other reports from my life with autism. New York: Vintage Books, 1996:62-81.
40. 6 on autistic children: a double-blind crossover study. Am J Psychiatry 1978;135:472-5.
41. 6 and magnesium in the treatment of autistic children and adults. In: Schopler E, Mesibov GB, eds. Neurobiological issues in autism. New York: Plenum, 1987:389-405.
42. Singh NN, Ellis CR, Mulick JA, Poling A. Vitamin, mineral and dietary treatments. In: Reiss S, Aman MG, eds. Psychotropic medications and developmental disabilities: the international consensus handbook. Columbus, Ohio: Ohio State University Nisonger Center, 1997:311-20.
43. Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998;9:9-15.
44. Chez MG, Buchanan CP, Bagan BT, Hammer MS, McCarthy KS, Ovrutskaya I, et al. Secretin and autism: a two-part clinical investigation. J Autism Dev Disord 2000;30:87-94.